PL354641A1 - Method of lowering the unfeed blood sugar level and increasing body weight with diabetics - Google Patents

Method of lowering the unfeed blood sugar level and increasing body weight with diabetics

Info

Publication number
PL354641A1
PL354641A1 PL02354641A PL35464102A PL354641A1 PL 354641 A1 PL354641 A1 PL 354641A1 PL 02354641 A PL02354641 A PL 02354641A PL 35464102 A PL35464102 A PL 35464102A PL 354641 A1 PL354641 A1 PL 354641A1
Authority
PL
Poland
Prior art keywords
unfeed
diabetics
lowering
body weight
blood sugar
Prior art date
Application number
PL02354641A
Other languages
English (en)
Inventor
William Harras Landschulz
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PL354641A1 publication Critical patent/PL354641A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PL02354641A 2001-06-21 2002-06-20 Method of lowering the unfeed blood sugar level and increasing body weight with diabetics PL354641A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30004901P 2001-06-21 2001-06-21

Publications (1)

Publication Number Publication Date
PL354641A1 true PL354641A1 (en) 2002-12-30

Family

ID=23157477

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02354641A PL354641A1 (en) 2001-06-21 2002-06-20 Method of lowering the unfeed blood sugar level and increasing body weight with diabetics

Country Status (15)

Country Link
US (2) US20030079747A1 (enExample)
EP (1) EP1270012A1 (enExample)
JP (1) JP2003012543A (enExample)
KR (1) KR20020097033A (enExample)
CN (1) CN1289143C (enExample)
AU (1) AU4884102A (enExample)
CA (1) CA2390757A1 (enExample)
CZ (1) CZ20022151A3 (enExample)
HK (1) HK1049617B (enExample)
HU (1) HUP0202042A3 (enExample)
IL (1) IL150209A0 (enExample)
NZ (1) NZ519403A (enExample)
PL (1) PL354641A1 (enExample)
SK (1) SK9042002A3 (enExample)
ZA (1) ZA200204859B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004054606A1 (en) * 2002-12-13 2004-07-01 Pfizer Products Inc. Method of decreasing hepatic glucose output in diabetic patients
WO2004078198A1 (en) * 2003-03-04 2004-09-16 The Technology Development Company Ltd. Long acting injectable insulin composition and methods of making and using thereof
US20070178166A1 (en) * 2005-12-15 2007-08-02 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
WO2008118387A2 (en) * 2007-03-23 2008-10-02 Wayne State University Erythrocyte atp-release modulators
EP2060268A1 (en) * 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmaceutical compositions for pulmonary or nasal delivery of peptides
CA2765617A1 (en) * 2009-07-22 2011-01-27 Eli Lilly And Company Method for predicting weight gain associated with a pharmaceutical therapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5230884A (en) * 1990-09-11 1993-07-27 University Of Wales College Of Cardiff Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
DK10191D0 (da) * 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
ES2141108T3 (es) * 1991-07-02 2000-03-16 Inhale Inc Metodo y dispositivo para proporcionar medicamentos en aerosol.
US5320094A (en) * 1992-01-10 1994-06-14 The Johns Hopkins University Method of administering insulin
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US5743250A (en) * 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US6024090A (en) * 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
DE69535897D1 (de) * 1994-03-07 2009-01-22 Nektar Therapeutics Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
ATE387925T1 (de) * 1994-09-21 2008-03-15 Nektar Therapeutics Vorrichtung und verfahren zum dispergieren von trockenen pulvermedikamenten
US5898028A (en) * 1997-03-20 1999-04-27 Novo Nordisk A/S Method for producing powder formulation comprising an insulin
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
CN1210058C (zh) * 1998-10-16 2005-07-13 诺沃挪第克公司 用于肺送递的稳定的浓缩胰岛素制剂
JP2002543092A (ja) * 1999-04-27 2002-12-17 イーライ・リリー・アンド・カンパニー 肺投与用インスリン結晶
AU5453300A (en) * 1999-06-29 2001-01-31 Eli Lilly And Company Insulin crystals for pulmonary administration
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
JP4590158B2 (ja) * 2001-04-04 2010-12-01 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド グルコース再吸収阻害剤およびレチノイド−ｘ受容体モジュレーターを含んで成る併用療法
KR20030097876A (ko) * 2001-05-21 2003-12-31 넥타르 테라퓨틱스 화학적으로 개질된 인슐린의 폐 투여

Also Published As

Publication number Publication date
CZ20022151A3 (cs) 2003-04-16
NZ519403A (en) 2005-03-24
JP2003012543A (ja) 2003-01-15
EP1270012A1 (en) 2003-01-02
US20030079747A1 (en) 2003-05-01
IL150209A0 (en) 2002-12-01
HUP0202042A3 (en) 2004-06-28
CN1289143C (zh) 2006-12-13
KR20020097033A (ko) 2002-12-31
CA2390757A1 (en) 2002-12-21
HU0202042D0 (enExample) 2002-08-28
CN1393265A (zh) 2003-01-29
HUP0202042A2 (hu) 2004-05-28
AU4884102A (en) 2003-01-02
HK1049617A1 (en) 2003-05-23
HK1049617B (zh) 2007-03-16
US20050220722A1 (en) 2005-10-06
SK9042002A3 (en) 2003-05-02
ZA200204859B (en) 2004-01-28

Similar Documents

Publication Publication Date Title
IL159816A0 (en) In-vivo method and device for improving diastolic function of the left ventricle
AU2002327430A8 (en) Methods for treating diabetes and other blood sugar disorders
IL158469A0 (en) Diagnosis, treatment, and research of mental disorder
AU2003259537A8 (en) Blood glucose level control
AU2002227353A1 (en) Use of targeted glycemic profiles in the calibration of a noninvasive blood glucose monitor
AU2003241347A1 (en) Medical catheter assembly and method of using the same
IL156844A0 (en) Noninvasive measurement of glucose through the optical properties of tissue
MXPA02007568A (es) Dispositivos para recolectar muestra fisiologica y metodos para utilizar los mismos.
PL1641918T3 (pl) Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia
EP1374935A4 (en) MEDICAL SYRINGE AND METHOD FOR THE PRODUCTION THEREOF
AU6353201A (en) Infusion of liquids into the human or animal body
AU2002305606A1 (en) Blood flow monitor for shock and resuscitation
GB0117169D0 (en) Respiration and heart rate monitor
IL160030A0 (en) Treatment of muscular dystrophy with cord blood cells
HRP20030928A2 (en) Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes
AU3213500A (en) Noninvasive measurement of blood sugar level
LU91070B1 (en) Treatment and diagnosis of insulin resistant states
AU2002322301A1 (en) Methods for the diagnosis and treatment of cardiac tissue rejection
ZA200204859B (en) Method of decreasing fasting sugars and weight gains in diabetic patients.
AU2002230509A1 (en) Devices and methods for treating low blood sugar levels
GB0014804D0 (en) Method of controlling blood sugar levels using coccoloba uvifera
AU2002240745A1 (en) Diagnosis and treatment of blood disorders
AU2002340655A1 (en) Non-invasive measurement of blood glucose level
AU2003263142A1 (en) Method and device for the non-invasive determination of the temperature in biological tissue
IL153452A0 (en) Treatment and prevention of cardiac insulin resistance associated conditions

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)